DNMT3A and acute myeloid leukemia: However, the subtlety in these results prevents us from making conclusions on a synthetic lethal relationship between DNMT1 and DNMT3A. Our studies suggest that a therapeutic window for DNMT1 methyltransferase inhibition in DNMT3A-driven AML may exist, but validation in more biologically relevant models will be required.